Rakuten Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Rakuten Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.27M	Buy	68,018 +9,877	+17%	+$329K	0.01%	388
2026 Q1	$1.65M	Buy	58,141 +8,815	+18%	+$284K	﹤0.01%	396
2025 Q4	$1.56M	Buy	49,326 +27,709	+128%	+$683K	0.01%	471
2025 Q3	$7.06M	Buy	+21,617	New	+$380K	0.03%	202
2025 Q1	$491K	Buy	+32,571	New	+$582K	﹤0.01%	572
2024 Q3	$377K	Buy	21,599 +5,364	+33%	+$93.9K	﹤0.01%	446
2024 Q2	$264K	Buy	16,235 +6,023	+59%	+$92.8K	﹤0.01%	447
2024 Q1	$144K	Buy	10,212 +9,345	+1,078%	+$118K	﹤0.01%	451
2023 Q4	$9.08K	Buy	+867	New	+$8.1K	﹤0.01%	490

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Rakuten Investment Management's TEVA Position: Q2 2026 in Review

Rakuten Investment Management increased its Teva Pharmaceuticals (TEVA) stake by 17% in Q2 2026, buying an estimated $329K and bringing the position to 68,018 shares worth $2.27M. The position accounts for 0.01% of the portfolio, ranked #388.

Rakuten Investment Management first reported a position in TEVA in Q4 2023 and has held it in 9 quarters since. The position peaked at $7.06M in Q3 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Rakuten Investment Management held 68,018 shares of Teva Pharmaceuticals worth $2.27M as of Q2 2026.
Rakuten Investment Management bought 9,877 Teva Pharmaceuticals shares in Q2 2026, an estimated $329K.
Teva Pharmaceuticals made up 0.01% of Rakuten Investment Management's portfolio in Q2 2026, its #388 holding.
Rakuten Investment Management first reported a position in Teva Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
Rakuten Investment Management's Teva Pharmaceuticals position peaked at $7.06M in Q3 2025.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Rakuten Investment Management's 13F filing for Q2 2026, filed 18 Aug 2026.